These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 483386)

  • 1. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves.
    Kuttler KL; Simpson JE
    Am J Vet Res; 1978 Feb; 39(2):347-9. PubMed ID: 629473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an experimental long-acting oxytetracycline (Terramycin/LA) in the treatment of acute anaplasmosis.
    Kuttler KL; Young MF; Simpson JE
    Vet Med Small Anim Clin; 1978 Feb; 73(2):187-92. PubMed ID: 245908
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline.
    Simpson CF
    Am J Vet Res; 1975 Oct; 36(10):1443-6. PubMed ID: 1190584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions.
    Kuttler KL; Johnson LW; Simpson JE
    Proc Annu Meet U S Anim Health Assoc; 1980; 84():73-82. PubMed ID: 6947300
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina.
    Sarli M; Novoa MB; Mazzucco MN; Morel N; Primo ME; de Echaide ST; Echaide IE
    Vet Parasitol Reg Stud Reports; 2021 Jan; 23():100513. PubMed ID: 33678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle.
    Coetzee JF; Apley MD; Kocan KM; Rurangirwa FR; Van Donkersgoed J
    Vet Parasitol; 2005 Jan; 127(1):61-73. PubMed ID: 15675047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a long-acting injectable oxytetracycline.
    Cornwell RL
    Mod Vet Pract; 1980 Nov; 61(11):945-7. PubMed ID: 7464772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.